Anna Piekarska

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Interim Analysis, Metabolic Associated Steatohepatitis, Hepatology +7

Real‐world effectiveness and safety of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C: AMBER study

Robert Flisiak, Ewa Janczewska, Marta Wawrzynowicz‐Syczewska et al. · Alimentary Pharmacology & Therapeutics · 2016 · 99 citations · Full text

Efficacy and safety of switching from boosted protease inhibitors plus emtricitabine and tenofovir disoproxil fumarate regimens to single-tablet darunavir, cobicistat, emtricitabine, and tenofovir alafenamide at 48 weeks in adults with virologically suppressed HIV-1 (EMERALD): a phase 3, randomised, non-inferiority trial

Chloe Orkin, Jean‐Michel Molina, Eugènia Negredo et al. · The Lancet HIV · 2017 · 96 citations

Protease Inhibitors, Treatment And Prevention, Pharmacology +9

Phenolic Composition and Antioxidant Properties of Polish Blue-Berried Honeysuckle Genotypes by HPLC-DAD-MS, HPLC Postcolumn Derivatization with ABTS or FC, and TLC with DPPH Visualization

Barbara Kusznierewicz, Anna Piekarska, Barbara Mrugalska et al. · Journal of Agricultural and Food Chemistry · 2012 · 95 citations

Food Chemistry, Dpph Visualization, Food Bioactive Compound +11

Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists as of April 26, 2021

Robert Flisiak, Andrzej Horban, Jerzy Jaroszewicz et al. · Polskie Archiwum Medycyny Wewnętrznej · 2021 · 88 citations · Full text